cognitive cybersecurity intelligence

News and Analysis

Search

Navigating Biotech’s New Normal, AI to Engineer Cas9 Enzymes, and Sequencing Generations

Navigating Biotech’s New Normal, AI to Engineer Cas9 Enzymes, and Sequencing Generations

This week’s news episode discussed the impact of job cuts in biotech, tariff threats on Roche’s R&D plans, and updates on Eli Lilly’s diabetes pill. DNA Day-related advances including machine learning designed Cas9 proteins and multi-platform sequencing technologies to study mutation rates across four generations were also discussed.

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts